Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma

3 Nov 2014

Abstract excerpt

BACKGROUND: Epithelial ovarian cancer (EOC) is the most common cause of gynecological malignancy-related mortality. Ovarian clear cell carcinoma (CCC) has unique clinical characteristics and behaviors that differ from other histological types of EOC, including a frequent association with endometriosis and a highly chemoresistant nature, resulting in poor prognosis. However, factors underlying its malignant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometriosis Research and Treatment
Share to MicroRNA in disease regulation
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25366985
DOI: 10.1186/1471-2407-14-799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinomaPMID 25366985Read ↗

PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinomaSemantic proximity Read ↗

Prognostic and therapeutic impact of the chromosome 20q13.2 <i>ZNF217</i> locus amplification in ovarian clear cell carcinomaSemantic proximity Read ↗

Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell AdenocarcinomaSemantic proximity Read ↗

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.Semantic proximity Read ↗

Molecular changes in endometriosis-associated ovarian clear cell carcinoma.Semantic proximity Read ↗

CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.Semantic proximity Read ↗

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma.Semantic proximity Read ↗

Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)Semantic proximity Read ↗

PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.Semantic proximity Read ↗

Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma ProgressionSemantic proximity Read ↗

MiR-146a-5p and miR-191-5p are the Candidates for Novel Diagnostic Markers of Ovarian Clear Cell CarcinomaSemantic proximity Read ↗

DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.